Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease in industrialized countries worldwide, and has become a serious public health issue …

Nonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver
disease in the western world. It is now recognized that these patients have myriad of …

Background Nonalcoholic steatohepatitis is a common liver disease that can progress to
cirrhosis. Currently, there is no established treatment for this disease. Methods We randomly …

4. Dr. Gregory Kaltsas MD FRCP (Lon) is a Professor in General Medicine and
Endocrinology at the National and Kapodistrian University of Athens, Greece. He was …

Non‐alcoholic fatty liver disease (NAFLD) is recognized as the most common type of chronic
liver disease in Western countries and the leading cause of cryptogenic cirrhosis. Insulin …

AIM: To study whether the severity of liver fibrosis estimated by the nonalcoholic fatty liver
disease (NAFLD) fibrosis score can predict all-cause mortality, cardiac complications, and/or …

Estimates of people suffering from overweight (one billion) and obesity (300 million) are
increasing. The accumulation of triglycerides in the liver, in the absence of excess alcohol …

Non-alcoholic fatty liver disease is an emerging liver disease in Western countries and the
most frequent cause of incidental elevation of serum liver enzymes. Dyslipidaemia is …

Adiponectin is an adipocyte-derived, antidiabetic, antiatherogenic adipocytokine that is
present in serum as 3 isoforms. Decreased plasma adiponectin levels are closely …

Liver-related diseases are the third-leading causes (9.3%) of mortality in type 2 diabetes
(T2D) in Japan. T2D is closely associated with nonalcoholic fatty liver disease (NAFLD) …